Phase 4
Completed N=42
Safety of Remifentanil Infusion
Urinary Tract Problem
Source: ClinicalTrials.gov NCT01303627 ↗
Enrolled (actual)
42
Serious AEs
—
Results posted
Jun 2012
Primary outcomePrimary: Smooth cLMA Removal Condition (Score 1) — 86; 40 percentage of participants — p=<0.05
Summary
The effect of maintenance remifentanil infusion with target controlled infusion during laryngeal mask airway removal on hemodynamic parameters and emergence quality is going to be investigated.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Smooth cLMA Removal Condition (Score 1) |
86; 40 | <0.05 sig |
Eligibility Criteria
Inclusion Criteria
- ASA I-II status
- aged 18-60 years old
- presenting for ureterorenoscopy
Exclusion Criteria
- history of hypertension
- asthma and chronic obstructive lung disease
- recent respiratory tract infections
Data sourced from ClinicalTrials.gov (NCT01303627). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.